Prognostic Role of Interleukin-23 in Prostate Adenocarcinoma: Comparison with Gallium-68 Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Computed Tomography Findings
Introduction:Androgen deprivation therapy is the first line of treatment for advanced prostate cancer (PC). However, PC progressed in most patients when it becomes resistant to castration. This study aimed to investigate the possible role of interleukin-23 (IL-23), a cytokine expressed in various ca...
Main Authors: | Cihan Gündoğan, Nurhan Ergül, Huriye Serin, Ediz Beyhan, Burçak Yılmaz, Tevfik Fikret Çermik |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2021-11-01
|
Series: | İstanbul Medical Journal |
Subjects: | |
Online Access: |
http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/prognostic-role-of-nterleukin-23-in-prostate-adeno/49717
|
Similar Items
-
The role of 68Gallium-prostate-specific membrane antigen positron emission tomography on staging of high-risk localized prostate cancer: for all high-risk patients or would it be better to select them?
by: Fernando Sabino M. Monteiro, et al.
Published: (2021-03-01) -
Automated radiolabelling of [68Ga]Ga-PSMA-11 (gallium (68Ga)-gozetotide) using the Locametz® kit and two generators
by: Elke A. van Brandwijk, et al.
Published: (2024-04-01) -
Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer
by: Nat P. Lenzo, et al.
Published: (2018-02-01) -
Diagnostic Impact of Dual-Time PET/CT with <sup>68</sup>Gallium-PSMA in Prostate Cancer and <sup>68</sup>Gallium-DOTATOC in Neuroendocrine Tumors
by: Damiano Librizzi, et al.
Published: (2023-03-01) -
Incidental prostate-specific membrane antigen-avid meningioma detected on 68Ga–prostate-specific membrane antigen PET/CT
by: James Yuheng Jiang, MD, MMed (ClinEpi), et al.
Published: (2021-11-01)